Picture a patient arriving at a comprehensive stroke center with sudden weakness on one side of the body and difficulty speaking. Imaging reveals not one but two separate blockages along the same arterial pathway — a severe narrowing or occlusion in the neck's extracranial carotid artery, paired with a second, distinct clot lodged further downstream in the middle cerebral artery (MCA) inside the skull. This combination, known as a tandem occlusion stroke, represents one of the more complex presentations that a neurointerventional team can encounter, because restoring blood flow requires addressing both lesions rather than just one.
What Exactly Is a Tandem Occlusion in Acute Stroke?
A tandem occlusion refers to the simultaneous presence of a significant blockage in the proximal, or extracranial, internal carotid artery together with an occlusion in a more distal intracranial vessel supplied by that same carotid, most commonly the MCA. The proximal carotid lesion is frequently caused by atherosclerotic plaque or, in some cases, arterial dissection, while the distal MCA occlusion is typically the result of a clot that has either formed locally or traveled from the proximal lesion itself. Because the two lesions sit along a single continuous blood supply route, treating only one of them generally does not fully restore normal flow to the affected brain territory.
Why Is Carotid Plus MCA Involvement More Complex Than a Single Blockage?
When a single MCA occlusion is present without a proximal carotid lesion, a neurointerventional team can often navigate a catheter directly to the clot without needing to address any additional narrowing along the way. In a tandem occlusion stroke, the same catheter must first cross or manage the carotid lesion before it can even reach the intracranial clot, which adds both technical steps and decision points to the procedure. The interventional team must also decide, often on a case-by-case basis, whether to treat the carotid lesion before, during, or after addressing the intracranial occlusion, and this sequencing is generally guided by the specific anatomy and clinical presentation involved.
How Are Tandem Occlusions Approached With Acute Stenting?
One common strategy involves acute stenting of the extracranial carotid lesion to restore a stable channel through the neck vessel, which then allows the interventional team to advance devices to the intracranial clot for mechanical thrombectomy. A stent retriever device, such as INVAMED's KinG Intracranial Revascularization Device, is used to capture and remove the clot from the intracranial artery once access has been achieved, according to the manufacturer's stated intended use for acute stroke therapy involving large vessel occlusion. The order of these steps, and whether stenting is performed before or after the intracranial portion of the procedure, is determined by the treating physician based on the individual patient's anatomy and angiographic findings.
Does Treatment Sequence Affect Outcomes in Complex Stroke Cases?
Clinicians generally consider several sequencing strategies for complex stroke cases involving tandem lesions, and no single order is applied universally across all patients. Some teams address the intracranial occlusion first to restore flow to the brain as quickly as possible, then return to the carotid lesion afterward. Others stabilize the carotid pathway first to create a clear route for subsequent intracranial work. The choice between these approaches depends on factors such as the stability of the carotid lesion, the estimated time each step will require, and the individual angiographic anatomy — decisions that a qualified physician makes in real time during the procedure.
Anticoagulation Considerations During Tandem Occlusion Procedures
Because acute stenting typically requires antiplatelet medication to reduce the risk of the newly placed stent clotting, and because the patient may separately be a candidate for clot-dissolving medication, balancing these treatments is a recognized challenge in tandem occlusion management. This balance is assessed individually by the treating team, weighing the benefits of restoring flow against bleeding risk considerations specific to that patient. No general dosing guidance is provided here, as these determinations belong to the clinical team managing the case. Devices used across these procedures are described on INVAMED's neurovascular interventions category page, and specific indications for the KinG device are detailed on its product page.
Why does the order of treating the two blockages matter?
The sequence in which the carotid and intracranial lesions are treated can affect technical access, procedure time, and how quickly blood flow is restored to the brain. Different treating teams may reasonably choose different sequences based on the specific anatomy and stability of each lesion. This decision is made in real time by the interventional team managing the case.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.